*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Serum Afamin As A Novel Biomarker for Non-Alcoholic Fatty Liver Disease as A Complication of Hypothyroidism in Iraqi Patients.

Author: MARWAH.SABAH ALTAIEE, TAGHREED. ULOOM. MOHAMMED, ANMAR DHIA ALDEEN MUHSIN
Abstract: Afamin, which is a human plasma glycoprotein, a putative multifunctional transporter of hydrophobic molecules and a marker for metabolic syndrome. Afamin concentration have been proposed to have a significant role as a predictor of metabolic disorders. Since NAFLD is associated with metabolic risk factors, e.g., dyslipidemia, insulin resistance and visceral obesity, it is considered as the hepatic manifestation of the metabolic syndrome. The objective of this study is to determine Afamin levels in hypothyroid patients with and without fatty liver disease and compare the results with controls. Also to study the relationship of Afamin level with the Anthropometric and Clinical Features (Age, Gender, BMI and Duration of Hypothyroidism) , Serum Thyroid Hormones (T3, T4 and TSH ), Lipid profile(Serum Cholesterol, TG and HDL), Liver Enzymes (GOT , GPT and ALP ) Levels , Renal Function Tests (blood Urea and serum Creatinine), Glycemic Parameters (F.B.S and HbA1c levels), Serum Hematological Parameters (PCV, MCV and WBC) and Serum Protein Parameters (Total Protein, serum albumin and serum Ferritin). Ninety individuals participated in this study and classified into three groups: G1: Hypothyroidism with fatty liver disease patients, G2: Hypothyroidism without fatty liver disease patients and G3: control subjects. All study cases were chosen from the Specialized Center in Endocrinology and Diabetes in alrisafa side / Baghdad. The age ranges of G1, G2 and G3 were (32-64), (23-67) and (24-40) years, respectively. Gender distribution shows increase in female to male ratio in all the studied groups. Results demonstrated the mean values of serum Afamin in G1 (277.688±157.725 ng/ml) and G2 (337.020±231.095 ng/ml) were very significantly higher (P=0.0001) than the mean serum Afamin in G3 (4.030±2.796 ng/ml), While the mean value of serum Afamin in G1 (277.688±157.725 ng/ml) was slightly lower than in G2 (337.020±231.095 ng/ml). The Receiving Operating Characteristic (ROC) curves analysis for serum Afamin used as a test to diagnose subjects into cases and control groups was done, and a determination of the “cut-off value” which have optimum sensitivity and specificity to diagnose disease was performed.
Keyword: : Afamin, Non-Alcoholic Fatty liver disease, Hypothyroidism, ROC analysis.
DOI: https://doi.org/10.31838/ijpr/2020.SP2.364
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free